
Cloxacillin
Description
Historical Trajectory of Beta-Lactam Antibiotic Development and Cloxacillin's Emergence
The history of beta-lactam antibiotics begins with Alexander Fleming's serendipitous discovery of penicillin from the mold Penicillium notatum (later identified as Penicillium rubens) wikipedia.org. This initial discovery laid the groundwork for an entirely new era of chemotherapy. Even before penicillin's widespread clinical application, observations indicated that bacteria possessed enzymatic mechanisms to degrade it, with the isolation of a penicillinase from E. coli in 1940 highlighting this emerging challenge researchgate.netfrontiersin.org.
The period spanning the 1950s to the 1970s is often regarded as a "golden era" for the discovery of novel antibiotic classes, driven by the continuous need to combat bacterial resistance frontiersin.org. This compound, a semisynthetic penicillin, emerged from this imperative wikipedia.orgnih.gov. It was patented in 1960 and subsequently approved for medical use in 1965 wikipedia.org. Its development by Beecham (now GlaxoSmithKline) was a direct response to the limitations of earlier penicillins, which were susceptible to inactivation by beta-lactamase enzymes produced by resistant bacterial strains wikipedia.orgpatsnap.com. This strategic development aimed to provide an effective therapeutic option against such resistant pathogens.
Classification and Structural Characteristics within the Penicillin Subclass
This compound is classified as a beta-lactam antibiotic and is a prominent member of the penicillin subclass biosynth.commerckmanuals.com. Like all penicillins, its core structure features a beta-lactam ring, which is critical for its antibacterial activity wikipedia.orgmerckmanuals.com. This compound is specifically recognized as a semisynthetic derivative, closely related to oxacillin, distinguished by a chlorination nih.gov.
A defining characteristic of this compound's molecular architecture is the presence of a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6 of its penicillin nucleus nih.govebi.ac.uk. This bulky side chain is integral to its unique properties. The full IUPAC name for this compound is (2S,5R,6R)-6-{[3-(2-chlorophenyl)-5-methyl-oxazole-4-carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid wikipedia.org. Its chemical formula is C19H18ClN3O5S, with a molar mass of 435.88 g·mol−1 wikipedia.orgnih.gov.
This compound belongs to a group known as isoxazolyl penicillins, which also includes compounds such as oxacillin, dithis compound, and fluthis compound taylorandfrancis.comunirioja.esnih.gov. These compounds share structural similarities but vary in their specific substituents, contributing to differences in properties like absorption unirioja.es. A key shared feature among isoxazolyl penicillins is their inherent resistance to staphylococcal beta-lactamase and stability in acidic environments, such as gastric acid taylorandfrancis.comunirioja.es.
Fundamental Principles of Beta-Lactamase Resistance in this compound
Bacterial resistance to beta-lactam antibiotics is frequently mediated by enzymes known as beta-lactamases (also referred to as penicillinases), which hydrolyze the crucial beta-lactam ring, rendering the antibiotic ineffective wikipedia.orgpatsnap.comwikipedia.org. This compound was specifically engineered to overcome this prevalent resistance mechanism, classifying it as a penicillinase-resistant beta-lactam antibiotic biosynth.comtaylorandfrancis.compatsnap.com.
The fundamental principle underlying this compound's resistance to beta-lactamase lies in the steric hindrance provided by its bulky isoxazolyl side chain wikipedia.orgpatsnap.com. This large R-group, incorporating the chlorophenyl and methyl moieties, physically impedes the beta-lactamase enzyme from effectively binding to and subsequently hydrolyzing the beta-lactam ring wikipedia.orgpatsnap.com. This structural modification is critical, allowing this compound to maintain its antibacterial activity against strains that produce beta-lactamase, particularly penicillinase-producing staphylococci patsnap.combiosynth.compatsnap.comhres.ca.
The primary mechanism of action for this compound, consistent with other beta-lactam antibiotics, involves the inhibition of bacterial cell wall synthesis patsnap.comunirioja.espatsnap.commims.comdrugbank.com. This compound achieves this by binding to specific penicillin-binding proteins (PBPs) located within the bacterial cell wall patsnap.commims.comdrugbank.com. PBPs are essential enzymes that catalyze the final transpeptidation step in the assembly of the peptidoglycan layer, which provides structural integrity to the bacterial cell patsnap.commims.com. By binding to these PBPs, this compound prevents the cross-linking of peptidoglycan chains, leading to a compromised and weakened cell wall, ultimately resulting in bacterial cell lysis patsnap.compatsnap.commims.com.
It is important to note that while this compound is effective against beta-lactamase-producing bacteria, certain resistance mechanisms, such as alterations in PBPs (e.g., in some borderline oxacillin-resistant Staphylococcus aureus (BORSA) strains), can render beta-lactamase inhibitors ineffective, as the resistance is not solely due to enzyme hyperproduction asm.org.
Molecular Mechanisms of this compound: A Detailed Examination
This compound, a semi-synthetic isoxazolyl penicillin antibiotic, exerts its antibacterial effects through a series of precise molecular interactions, primarily targeting the integrity of the bacterial cell wall. nih.govpatsnap.com This article delves into the intricate mechanisms of this compound's action, from its inhibition of crucial enzymes to the stereochemical factors governing its efficacy.
Properties
IUPAC Name |
(2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
---|---|---|
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI |
InChI=1S/C19H18ClN3O5S/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27)/t13-,14+,17-/m1/s1 | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
InChI Key |
LQOLIRLGBULYKD-JKIFEVAISA-N | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Canonical SMILES |
CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Isomeric SMILES |
CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Molecular Formula |
C19H18ClN3O5S | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
DSSTOX Substance ID |
DTXSID5022853 | |
Record name | 6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido) penicillanic acid | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID5022853 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Molecular Weight |
435.9 g/mol | |
Source | PubChem | |
URL | https://pubchem.ncbi.nlm.nih.gov | |
Description | Data deposited in or computed by PubChem | |
Physical Description |
Solid | |
Record name | Cloxacillin | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0015278 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Solubility |
WHITE, CRYSTALLINE POWDER; SOL IN ALCOHOL; SLIGHTLY SOL IN ACETONE, CHLOROFORM; AQ SOLN IS ALKALINE; DECOMP BETWEEN 170 °C & 173 °C; ODORLESS; BITTER TASTE /MONOHYDRATE/, 5.32e-02 g/L | |
Record name | CLOXACILLIN | |
Source | Hazardous Substances Data Bank (HSDB) | |
URL | https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3042 | |
Description | The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel. | |
Record name | Cloxacillin | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0015278 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
CAS No. |
61-72-3 | |
Record name | Cloxacillin | |
Source | CAS Common Chemistry | |
URL | https://commonchemistry.cas.org/detail?cas_rn=61-72-3 | |
Description | CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society. | |
Explanation | The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated. | |
Record name | Cloxacillin [INN:BAN] | |
Source | ChemIDplus | |
URL | https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000061723 | |
Description | ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system. | |
Record name | Cloxacillin | |
Source | DrugBank | |
URL | https://www.drugbank.ca/drugs/DB01147 | |
Description | The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. | |
Explanation | Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode) | |
Record name | 6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido) penicillanic acid | |
Source | EPA DSSTox | |
URL | https://comptox.epa.gov/dashboard/DTXSID5022853 | |
Description | DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. | |
Record name | Cloxacillin | |
Source | European Chemicals Agency (ECHA) | |
URL | https://echa.europa.eu/substance-information/-/substanceinfo/100.000.468 | |
Description | The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness. | |
Explanation | Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page. | |
Record name | CLOXACILLIN | |
Source | FDA Global Substance Registration System (GSRS) | |
URL | https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O6X5QGC2VB | |
Description | The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions. | |
Explanation | Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required. | |
Record name | CLOXACILLIN | |
Source | Hazardous Substances Data Bank (HSDB) | |
URL | https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3042 | |
Description | The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel. | |
Record name | Cloxacillin | |
Source | Human Metabolome Database (HMDB) | |
URL | http://www.hmdb.ca/metabolites/HMDB0015278 | |
Description | The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body. | |
Explanation | HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications. | |
Antimicrobial Spectrum, Efficacy, and Susceptibility Research
In Vitro Susceptibility Profiling of Cloxacillin against Bacterial Isolates
The in vitro susceptibility of bacterial isolates to this compound is a critical determinant in guiding therapeutic choices. Various laboratory methods are employed to assess the effectiveness of this compound against specific pathogens, providing essential data on its antimicrobial spectrum.
This compound, a penicillinase-stable penicillin, demonstrates significant activity primarily against Gram-positive bacteria, with a particular emphasis on Staphylococcus aureus. researchgate.net Its development was a direct response to the emergence of penicillinase-producing strains of S. aureus that rendered earlier penicillins ineffective. banglajol.info
Research has consistently shown that this compound is effective against penicillinase-producing staphylococci. researchgate.net However, the emergence of methicillin-resistant Staphylococcus aureus (MRSA) has presented a significant challenge, as these strains are also resistant to this compound. banglajol.inforesearchgate.net Studies have identified MRSA strains exhibiting high levels of resistance to this compound, with some showing 100% resistance. researchgate.net
Conversely, for methicillin-susceptible Staphylococcus aureus (MSSA), this compound remains a viable therapeutic agent. nih.gov Some studies have even explored the phenomenon of "tolerance," where certain S. aureus strains, while having a low minimum inhibitory concentration (MIC) to this compound, are not effectively killed by it. nih.gov The clinical significance of this tolerance, however, remains a subject of investigation. nih.gov
The table below summarizes the susceptibility of different Staphylococcus aureus strains to this compound based on various studies.
Strain Type | Susceptibility to this compound | Key Findings |
Penicillinase-producing S. aureus | Generally Susceptible | This compound is stable against the penicillinase enzyme. banglajol.info |
Methicillin-resistant S. aureus (MRSA) | Resistant | MRSA strains often exhibit high-level resistance to this compound. banglajol.inforesearchgate.net |
Methicillin-susceptible S. aureus (MSSA) | Susceptible | This compound is an effective agent against MSSA. nih.gov |
This compound-tolerant S. aureus | Low MIC, but not effectively killed | A phenomenon observed in some strains, though its clinical impact is debated. nih.gov |
The minimum inhibitory concentration (MIC) is a fundamental measure in microbiology, representing the lowest concentration of an antimicrobial agent that prevents the visible growth of a microorganism. banglajol.info Several standardized methods are utilized to determine the MIC of this compound. researchgate.net
The agar dilution method is a well-established technique for determining the MIC of antimicrobial agents. researchgate.net In this method, varying concentrations of this compound are incorporated into an agar medium. researchgate.netbanglajol.info Each plate contains a different, specific concentration of the antibiotic. researchgate.net
The bacterial isolates to be tested are then inoculated onto the surface of these plates. nih.gov This can be done efficiently using an inoculum-replicating apparatus that transfers multiple inocula simultaneously. researchgate.net After incubation, the plates are examined for bacterial growth. The MIC is recorded as the lowest concentration of this compound that completely inhibits the visible growth of the organism. banglajol.info
For example, a study determining the MIC of this compound for MRSA strains used agar plates with concentrations of 128 μg/ml, 64 μg/ml, 32 μg/ml, 16 μg/ml, 8 μg/ml, 4 μg/ml, 2 μg/ml, and 1 μg/ml. banglajol.info The results from such studies can reveal high levels of resistance, with some MRSA strains growing even at concentrations of ≥128 μg/ml. banglajol.inforesearchgate.net
The disk diffusion assay, commonly known as the Kirby-Bauer method, is a widely used qualitative test for determining the susceptibility of bacteria to antibiotics. mymicrolab.comtmmedia.in This method is based on the principle of diffusion. An antibiotic-impregnated paper disk, containing a specific amount of this compound (e.g., 1 mcg or 5 mcg), is placed on an agar plate that has been uniformly inoculated with the test bacterium. mymicrolab.commicromasterlab.com
As the disk absorbs moisture from the agar, the this compound diffuses outward, creating a concentration gradient in the agar. tmmedia.in The concentration is highest near the disk and decreases with distance. mymicrolab.comtmmedia.in After an incubation period, typically 16-20 hours at 35 ± 2°C, a clear zone of inhibition will be visible around the disk if the bacteria are susceptible to this compound. mymicrolab.comhimedialabs.com The diameter of this zone is measured and compared to standardized charts to determine if the organism is susceptible, intermediate, or resistant. himedialabs.com
Mueller-Hinton Agar is the recommended medium for this test due to its reproducibility and low levels of inhibitors. mymicrolab.comtmmedia.in It is important to note that for detecting methicillin-resistant strains of S. aureus, incubation at 35°C or below is crucial, as resistance may be missed at 37°C. nih.gov Interestingly, some research suggests that 1-μg this compound disks may not reliably differentiate between sensitive and resistant staphylococci. nih.gov
The microbroth dilution method is another quantitative technique for determining the MIC of this compound. This method involves using a series of wells in a microtiter plate, each containing a different concentration of the antibiotic in a liquid growth medium (broth). nih.govnih.gov
A standardized suspension of the test bacteria is added to each well. frontiersin.org The plates are then incubated, and the wells are observed for turbidity, which indicates bacterial growth. The MIC is the lowest concentration of this compound that shows no visible growth. idexx.dk
This method is amenable to automation and is considered a reference method by organizations like the Clinical and Laboratory Standards Institute (CLSI). researchgate.net In one study, the MIC of this compound against S. aureus was determined using a two-fold serial dilution in broth, with concentrations ranging from 256 to 0.007 μg/mL. frontiersin.org
The table below provides a comparative overview of the MIC determination methodologies.
Method | Principle | Advantages | Disadvantages |
Agar Dilution | Antibiotic is incorporated into agar at various concentrations. | Can test multiple isolates simultaneously; provides a quantitative result (MIC). | Labor-intensive to prepare plates. |
Disk Diffusion (Kirby-Bauer) | Antibiotic diffuses from a paper disk into the agar, creating a zone of inhibition. | Simple, cost-effective, and widely used for routine testing. micromasterlab.com | Provides a qualitative result (susceptible, intermediate, resistant); less precise than dilution methods. |
Microbroth Dilution | Serial dilutions of the antibiotic are made in broth in a microtiter plate. | Provides a quantitative result (MIC); amenable to automation; uses small volumes of reagents. | Requires specialized equipment for high-throughput testing. |
Time-kill kinetic studies are performed to evaluate the bactericidal (killing) or bacteriostatic (inhibiting growth) activity of an antimicrobial agent over time. These studies provide a dynamic view of the interaction between the antibiotic and the bacteria.
In a typical time-kill assay, a standardized inoculum of bacteria is exposed to a specific concentration of this compound (often at multiples of the MIC) in a liquid culture medium. Samples are then taken at various time points (e.g., 0, 2, 4, 6, 8, 24 hours), diluted, and plated to determine the number of viable bacteria (colony-forming units per milliliter or CFU/mL). nih.gov
A bactericidal effect is generally defined as a ≥3-log10 (or 99.9%) reduction in the initial bacterial count. abjournals.org Research has shown that the bactericidal activity of this compound can be concentration-dependent. For instance, in a study on a tolerant S. aureus strain, a lower concentration of this compound (0.5 mg/L) resulted in a greater reduction in bacterial numbers after 6 and 24 hours compared to higher concentrations (2.5 and 25 mg/L), a phenomenon known as a paradoxical effect.
Time-kill curves graphically represent the change in bacterial viability over time. These curves can demonstrate the speed and extent of bacterial killing. For example, some studies have shown that the combination of this compound with other antibiotics, like daptomycin, can enhance the bactericidal effect against both MSSA and MRSA. nih.govasm.org
Minimum Inhibitory Concentration (MIC) Determination Methodologies
Disk Diffusion Assays (Kirby-Bauer Method)
Comparative Antimicrobial Efficacy Studies in Preclinical Models and In Vitro Systems
This compound, a penicillinase-resistant beta-lactam, is frequently compared to other antibiotics to establish its relative efficacy, particularly against susceptible and resistant bacterial strains. In preclinical and in vitro settings, its performance varies depending on the comparator drug and the target organism.
Studies comparing this compound to other beta-lactams often focus on its activity against Staphylococcus aureus. In the treatment of methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, retrospective cohort studies have found no significant difference in 90-day mortality between definitive treatment with this compound and the first-generation cephalosporin, cefazolin. researchgate.netnih.gov However, empirical treatment with this compound or cefazolin was associated with lower 30-day mortality compared to treatment with third-generation cephalosporins (ceftriaxone, cefotaxime) or beta-lactam/beta-lactamase inhibitor combinations. researchgate.net An in vitro study investigating coagulase-negative staphylococci found more strains were resistant to this compound and oxacillin than to dithis compound and fluthis compound. nih.gov A combination of amoxicillin-cloxacillin demonstrated synergy and proved effective against clinical isolates of S. aureus, including those resistant to a combination of ampicillin-cloxacillin. ajol.info
When compared with non-beta-lactam antibiotics, this compound's efficacy is context-dependent. Against MSSA in a rabbit model of experimental endocarditis, the combination of daptomycin and this compound significantly reduced the bacterial load. researchgate.net In a separate foreign-body infection model using MSSA, this compound monotherapy was found to be less active than combination therapies, such as this compound-daptomycin or this compound-rifampin. asm.org While some research points to the superiority of beta-lactams over glycopeptides like vancomycin for MSSA infections, a mouse peritonitis model did not show evidence of a synergistic or additive effect when this compound was combined with vancomycin. researchgate.netresearchgate.net The discovery of non-β-lactam inhibitors, such as oxadiazoles, which target penicillin-binding proteins (PBPs), presents a novel comparison point, with these new compounds showing activity against MRSA. acs.org
Comparator Antibiotic | Class | Target Organism(s) | Key Comparative Finding | Source |
---|---|---|---|---|
Cefazolin | Beta-Lactam (Cephalosporin) | MSSA | No significant difference in mortality for definitive treatment of bacteremia compared to this compound. | researchgate.netnih.gov |
Amoxicillin | Beta-Lactam (Penicillin) | S. aureus | Amoxicillin-cloxacillin combination showed synergy and was effective against ciprofloxacin-resistant isolates. | ajol.info |
Dithis compound / Fluthis compound | Beta-Lactam (Penicillin) | Coagulase-negative staphylococci | Fewer strains were resistant to dithis compound and fluthis compound compared to this compound. | nih.gov |
Daptomycin | Non-Beta-Lactam (Lipopeptide) | MSSA | Combination with this compound was effective in experimental endocarditis and foreign-body infection models. | researchgate.netasm.org |
Vancomycin | Non-Beta-Lactam (Glycopeptide) | MRSA | No synergistic or additive effect was observed when combined with this compound in a mouse peritonitis model. | researchgate.net |
Ciprofloxacin | Non-Beta-Lactam (Fluoroquinolone) | S. aureus | All ciprofloxacin-resistant isolates tested were sensitive to an amoxicillin-cloxacillin combination. | ajol.info |
The efficacy of this compound can be significantly altered when administered with other compounds. In vitro studies have identified both synergistic and antagonistic interactions with a range of other drugs.
Synergism, where the combined effect is greater than the sum of individual effects, has been observed with several antibiotics. A notable synergistic partner is the aminoglycoside netilmicin, which, in combination with this compound, showed a synergistic effect against a reference strain of S. aureus both in vitro and in vivo. nih.gov Combinations with daptomycin and fosfomycin have also demonstrated synergistic activity against methicillin-sensitive S. aureus (MSSA) in time-kill curve studies. researchgate.net A screen of FDA-approved drugs identified that this compound, along with other beta-lactamase-resistant penicillins, had the greatest synergy with the fifth-generation cephalosporin ceftobiprole against methicillin-resistant S. aureus (MRSA). asm.org Beyond conventional antibiotics, the essential oil of Melaleuca armillaris showed a clear synergistic effect when combined with this compound against S. aureus, significantly decreasing the concentration of the antibiotic needed to inhibit bacterial growth. frontiersin.org this compound can also inhibit AmpC β-lactamases, leading to a significant reduction in the minimum inhibitory concentrations (MICs) of carbapenems (imipenem, meropenem) and cephalosporins (ceftazidime, cefepime) against resistant Pseudomonas aeruginosa isolates. nih.gov
Conversely, antagonism has been documented, particularly with bacteriostatic antibiotics. Tetracyclines, such as doxycycline and tetracycline itself, may reduce the therapeutic effect of penicillins like this compound by inhibiting protein synthesis, which is necessary for the cell wall synthesis inhibition pathway of penicillins. drugbank.comdrugs.com Similarly, some in vitro data indicate that macrolide antibiotics, including clarithromycin and erythromycin, can act antagonistically with penicillins, although other data have shown synergism, leading to unpredictable therapeutic efficacy when combined. drugs.comdrugs.com
Co-Administered Compound | Compound Class | Interaction Type | Target Organism(s) | Source |
---|---|---|---|---|
Netilmicin | Aminoglycoside | Synergistic | S. aureus | nih.gov |
Daptomycin | Lipopeptide | Synergistic | MSSA | researchgate.netasm.org |
Fosfomycin | Phosphonic Acid Derivative | Synergistic | MSSA | researchgate.net |
Ceftobiprole | Cephalosporin | Synergistic | MRSA | asm.org |
Essential Oil of Melaleuca armillaris | Phytochemical | Synergistic | S. aureus | frontiersin.org |
Cinnamic Acid Derivatives | Phenolic Acid | Synergistic | S. epidermidis | mdpi.com |
Tetracycline / Doxycycline | Tetracycline | Antagonistic | General (Penicillins) | drugbank.comdrugs.com |
Clarithromycin / Erythromycin | Macrolide | Antagonistic (conflicting data exists) | General (Penicillins) | drugs.comdrugs.com |
Comparison with Other Beta-Lactams and Non-Beta-Lactam Antibiotics
This compound's Impact on Bacterial Biofilm Formation and Eradication
This compound exhibits a complex, often concentration-dependent, relationship with bacterial biofilms. Research indicates it can both induce the formation of biofilms at low concentrations and inhibit or eradicate them at higher concentrations.
A significant body of evidence shows that sub-inhibitory concentrations of this compound can paradoxically promote biofilm formation in several bacterial species. plos.orgfrontiersin.org This effect has been documented in both Staphylococcus aureus and Staphylococcus epidermidis. plos.orgumh.es Studies suggest this antibiotic-induced biofilm formation may be a protective stress response by the bacteria. acs.org For instance, in methicillin-resistant S. epidermidis (MRSE), sub-MIC levels of this compound were found to significantly enhance biofilm production. plos.org Similarly, some beta-lactams, including this compound, have been shown to induce biofilm formation in S. aureus through a mechanism linked to the release of extracellular DNA (eDNA). frontiersin.org
Conversely, at sufficient concentrations, this compound can effectively inhibit the initial stages of biofilm formation and help eradicate mature biofilms. acs.orgdovepress.com In a study on S. epidermidis, this compound alone achieved a 95.28% reduction in biofilm. mdpi.com The efficacy of this compound against biofilms is often enhanced when used in combination with other agents. For example, combinations of cinnamic acid derivatives with this compound resulted in biofilm growth reductions of up to 95.51%. mdpi.com An in vivo model of a catheter-associated infection showed that this compound administered at a concentration equivalent to its biofilm MIC (bMIC) significantly reduced bacterial colonization on the catheter, whereas concentrations at the standard MIC had a limited effect. vivexia.frresearchgate.net However, other research has found this compound to be effective in eradicating planktonic cultures of S. aureus but not established biofilms. dovepress.com
Condition | Target Organism | Effect | Biofilm Reduction/Induction (%) | Source |
---|---|---|---|---|
This compound (alone) | S. epidermidis | Reduction | 95.28% | mdpi.com |
This compound + Sinapic Acid | S. epidermidis | Reduction | 95.51% | mdpi.com |
This compound + Cinnamic Acid | S. epidermidis | Reduction | 90.53% | mdpi.com |
This compound + Ferulic Acid | S. epidermidis | Reduction | 88.95% | mdpi.com |
This compound at sub-MIC (4 µg/mL) | S. epidermidis ATCC 35984 | Induction | 90% (Biofilm Induction) | acs.org |
This compound at sub-MIC concentrations | MRSE (clinical isolates) | Induction | Variable increase in optical density (0.09–0.95) | plos.org |
This compound at bMIC | S. aureus | Reduction (in vivo) | Significant reduction in catheter colonization (2.7-3.1 log reduction) | vivexia.frresearchgate.net |
Chemical Synthesis, Structural Elucidation, and Derivatization
Semi-Synthetic Production Pathways of Cloxacillin
This compound is classified as a semi-synthetic penicillin, meaning it is derived from a naturally occurring penicillin nucleus that is subsequently modified through chemical reactions. The fundamental building block for this compound and other semi-synthetic penicillins is 6-aminopenicillanic acid (6-APA) bocsci.comnih.gov. 6-APA is the core bicyclic structure common to all penicillins, comprising a β-lactam ring fused to a thiazolidine ring [Search Result 19 from previous turn].
The semi-synthetic nature allows for the introduction of various side chains at the 6-amino position of 6-APA, thereby tailoring the antimicrobial properties of the resulting antibiotic [Search Result 4 from previous turn]. This approach has been instrumental in developing penicillins with improved stability against enzymatic degradation and altered spectrums of activity.
Precursor Chemistry and Reaction Mechanisms
The production of this compound primarily involves the acylation of the 6-amino group of 6-aminopenicillanic acid (6-APA) with a specific acylating agent. The key side chain incorporated into this compound is the 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group bocsci.comnih.gov.
A common pathway for this compound synthesis involves the direct condensation reaction between 6-aminopenicillanic acid (often in its sodium salt form) and 3-(2-chlorophenyl)-5-methylisoxazole-4-carbonyl chloride (or a similar acyl halide). This reaction forms an amide linkage at the 6-position of the 6-APA nucleus. Subsequent acidification and salt formation steps yield this compound sodium [Search Result 12 from previous turn].
An alternative, more elaborate synthetic route for the side chain involves starting with benzoic acid and ethyl bromoacetate to produce benzoylacetic acid ethyl ester. This ester then reacts with 6-aminopenicillanic acid to form benzoyl-6-aminopenicillanic acid. Further chemical transformations, including reactions with sulfonyl chloride and an aldolamine, followed by acidic hydrolysis to remove protecting groups, ultimately lead to the this compound structure bocsci.com. However, the direct acylation of 6-APA is the defining semi-synthetic step.
Structure-Activity Relationship (SAR) Studies of this compound and its Analogs
Structure-Activity Relationship (SAR) studies are crucial in medicinal chemistry for understanding how modifications to a molecule's structure influence its biological activity. For this compound, SAR investigations have focused on its resistance to β-lactamase enzymes and the impact of its stereochemistry on potency.
Impact of Substituent Modifications on Beta-Lactamase Stability
This compound's notable resistance to β-lactamase enzymes, which are produced by certain bacteria to inactivate penicillin antibiotics by hydrolyzing their β-lactam ring, is primarily due to the bulky isoxazole side chain attached at the 6-position of the penicillin nucleus patsnap.comontosight.aijopir.in. This bulky group, specifically the 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido moiety, creates steric hindrance around the β-lactam ring. This steric bulk physically impedes the β-lactamase enzyme from accessing and binding to the susceptible β-lactam bond, thereby preventing its hydrolysis and preserving the antibiotic's activity patsnap.com.
Further modifications, such as the introduction of a chlorine atom at position 2' of the phenyl ring (as seen in this compound itself, compared to oxacillin which lacks this chlorine) or two fluorine atoms (as in dithis compound), further enhance stability against β-lactamase hydrolysis [Search Result 17 from previous turn]. This highlights the importance of the nature and position of substituents on the aromatic ring within the side chain for conferring β-lactamase resistance.
Influence of Stereochemistry on Biological Potency
The three-dimensional arrangement of atoms, or stereochemistry, plays a pivotal role in the biological activity of this compound and other β-lactam antibiotics. The absolute stereochemistry of this compound is precisely defined as (2S,5R,6R) nih.gov. This specific configuration is critical for the molecule's ability to interact effectively with its biological targets, primarily the penicillin-binding proteins (PBPs) located within the bacterial cell wall [Search Result 16 from previous turn, Search Result 19 from previous turn].
β-Lactam antibiotics exert their bactericidal effect by covalently binding to the active site serine residue of PBPs, which are enzymes essential for the cross-linking of peptidoglycans during bacterial cell wall synthesis [Search Result 20 from previous turn, Search Result 24 from previous turn]. The precise spatial orientation dictated by the (2S,5R,6R) stereochemistry ensures optimal fit and interaction with the PBP active site, leading to the formation of a stable acyl-enzyme complex that inhibits cell wall synthesis [Search Result 20 from previous turn]. Any alteration in this specific stereochemistry can significantly reduce the antibiotic's potency and increase its susceptibility to enzymatic degradation by penicillinases [Search Result 22 from previous turn].
Design and Synthesis of Novel this compound Derivatives with Modified Antimicrobial Properties
The ongoing challenge of antimicrobial resistance necessitates the continuous design and synthesis of novel derivatives with improved or altered antimicrobial properties. While direct modifications to the core this compound structure are explored, research also extends to synthesizing compounds with similar structural motifs, particularly the isoxazole ring, to achieve enhanced activity.
For instance, studies have focused on synthesizing novel isoxazole derivatives that share structural characteristics with the side chain of this compound. These efforts aim to identify compounds with superior antibacterial activity against both Gram-negative and Gram-positive bacteria, including resistant strains.
An example of such research involves the synthesis and antibacterial screening of N3, N5-di(substituted)isoxazole-3,5-diamine derivatives. These compounds, while not direct this compound derivatives, incorporate the isoxazole moiety central to this compound's side chain. Research findings indicate that certain modifications to these isoxazole structures can lead to enhanced antimicrobial properties. For example, the presence of electron-withdrawing groups, such as fluorine and chlorine, at the para position of the phenyl rings generally increased antibacterial activity.
The following table illustrates the comparative minimum inhibitory concentrations (MICs) of some novel isoxazole derivatives against common bacterial strains, demonstrating their modified antimicrobial properties relative to this compound:
Table 1: Comparative MIC Values of Novel Isoxazole Derivatives vs. This compound
Compound | Escherichia coli (MIC, µg/mL) | Staphylococcus aureus (MIC, µg/mL) |
This compound | 120 | 110 |
178d | 117 | 105 |
178e | 110 | 98 |
178f | 95 | 85 |
Note: Lower MIC values indicate higher antibacterial potency.
This data suggests that strategic modifications to the isoxazole scaffold can yield compounds with improved antibacterial efficacy, surpassing that of this compound against certain strains. Such findings contribute to the broader understanding of SAR within the β-lactam class and guide the rational design of future antimicrobial agents.
Pharmacological Research in Preclinical and in Vitro Systems
Pharmacodynamic Principles Governing Cloxacillin's Efficacy in Research Models
This compound is a semisynthetic penicillin antibiotic that exerts its bactericidal activity by interfering with the synthesis of the bacterial cell wall. This mechanism involves the binding of this compound to specific penicillin-binding proteins (PBPs) located within the bacterial cell wall, thereby inhibiting the final transpeptidation step of peptidoglycan synthesis. nih.govwikipedia.orgwikipedia.orgwikipedia.orgwikipedia.orgmims.com The integrity of the β-lactam ring is crucial for its antibacterial activity, and this compound is particularly effective against penicillinase-producing Staphylococcus aureus strains due to the steric hindrance provided by its acyl side chain, which prevents bacterial penicillinase from attacking and opening the β-lactam ring. wikipedia.orgnih.gov
Pharmacodynamic models have been extensively utilized to establish the in vitro efficacy of this compound against various bacterial strains, notably Staphylococcus aureus. These models aim to quantify the relationship between antibiotic concentration and the resulting bacterial killing rate over time. Research has demonstrated that the killing rate of this compound is dependent on both concentration and time. fishersci.fiwikidata.org Studies determining the 50% effective concentration (EC50) for this compound against two Staphylococcus aureus strains reported values of 0.105 mg/liter and 0.121 mg/liter, respectively. fishersci.fiwikidata.org These parameters derived from in vitro pharmacodynamic models have shown satisfactory predictive capabilities for bacterial colony-forming unit (CFU) counts under exponentially decreasing concentrations in vitro (R² between 0.862 and 0.894). fishersci.fiwikidata.org
Mechanistic Investigations of this compound's Interactions with Other Compounds (Non-Clinical)
Mechanistic investigations in non-clinical settings have shed light on this compound's interactions with other antimicrobial agents and compounds. This compound has been identified as an inhibitor of AmpC β-lactamases. wikipedia.orgwikipedia.org This inhibitory activity is particularly significant in the context of antibiotic resistance. For instance, in vitro studies have demonstrated that this compound can significantly reduce the minimum inhibitory concentrations (MICs) of carbapenems (such as imipenem and meropenem) and cephalosporins (such as ceftazidime and cefepime) when combined against carbapenem-resistant Pseudomonas aeruginosa isolates. wikipedia.org The MICs of these antibiotics, which ranged from 1-256 µg/mL for carbapenems and 4-1024 µg/mL for cephalosporins when used alone, were reduced to 1-32 µg/mL and 1-512 µg/mL, respectively, in combination with this compound, indicating a potential synergistic effect attributed to this compound's AmpC β-lactamase inhibition. wikipedia.org
However, not all interactions are beneficial. Penicillinase-resistant penicillins, including this compound, have been shown to be physically and/or chemically incompatible with aminoglycosides in vitro, leading to the inactivation of aminoglycoside drugs. wikipedia.orgwikipedia.org This inactivation can also occur in serum samples obtained from patients receiving concomitant therapy, which could adversely affect the results of serum aminoglycoside assays. wikipedia.org Furthermore, bacteriostatic drugs, such as chloramphenicol, erythromycin, sulfonamides, and tetracyclines, may interfere with the bactericidal effect of this compound. wikipedia.orgmims.com This antagonism highlights the importance of understanding drug-drug interactions at a mechanistic level in preclinical research. In another instance of non-clinical interaction, quinine has been observed to decrease the antimicrobial activity of this compound in vitro, resulting in a five- to sevenfold increase in the MIC of this compound. fishersci.ca
Table 3: Effect of this compound on MICs of Other Antibiotics Against Carbapenem-Resistant Pseudomonas aeruginosa Isolates (In Vitro) wikipedia.org
Antibiotic Combination | MIC Range Alone (µg/mL) | MIC Range with this compound (µg/mL) |
Imipenem (IMI) | 1-256 | 1-32 |
Meropenem (MEM) | 1-256 | 1-32 |
Ceftazidime (CAZ) | 4-1024 | 1-512 |
Cefepime (FEP) | 4-1024 | 1-512 |
Analytical Methodologies and Impurity Profiling of Cloxacillin
Development and Validation of Chromatographic Techniques for Cloxacillin Quantification
Chromatographic techniques are the cornerstone for the analysis of this compound in bulk drug substances, pharmaceutical formulations, and biological matrices. thepharmajournal.comafricaresearchconnects.comnih.gov These methods offer high selectivity and sensitivity, allowing for the separation and quantification of this compound from related substances and degradation products. nih.govchromatographyonline.com
High-Performance Liquid Chromatography (HPLC) with Various Detectors (UV, DAD, FLD)
High-Performance Liquid Chromatography (HPLC) is the most widely employed technique for this compound analysis. mdpi.comresearchgate.netnih.gov Reversed-phase HPLC (RP-HPLC) methods are particularly common, utilizing C18 or similar stationary phases. thepharmajournal.comafricaresearchconnects.comnih.gov
Detectors:
Ultraviolet (UV) Detector: UV detectors are frequently used for the quantification of this compound, typically at a wavelength of around 225 nm. thepharmajournal.comafricaresearchconnects.comnih.gov They are robust and cost-effective for routine analysis. phenomenex.com
Diode-Array Detector (DAD): DAD provides the advantage of acquiring spectra across a range of wavelengths simultaneously. mdpi.comphenomenex.comnih.gov This capability is invaluable for peak purity assessment and identification of co-eluting impurities. phenomenex.comscioninstruments.com
Fluorescence Detector (FLD): While less common for this compound itself, which is not naturally fluorescent, FLD can be used after derivatization to enhance sensitivity for specific applications. mdpi.comscioninstruments.com
Several studies have reported the development and validation of HPLC methods for this compound. For instance, a simple, sensitive, and rapid RP-HPLC method was developed for determining this compound sodium in bulk and pharmaceutical dosage forms using a UV-Visible detector at 224 nm. thepharmajournal.com The method demonstrated good linearity and precision. thepharmajournal.com Another study detailed a stability-indicating RP-UPLC method, an advancement from HPLC, which offered reduced analysis time and higher resolution for separating this compound from its degradation products. nih.govoup.com
Interactive Table: HPLC Methods for this compound Quantification
Stationary Phase | Mobile Phase | Detector | Wavelength (nm) | Application | Reference |
Thermo C18 | 20mM KH2PO4 (pH 3.0): Acetonitrile (20:80) | UV-Visible | 224 | Bulk and pharmaceutical dosage form | thepharmajournal.com |
P. Hypersorb ODS | Acetonitrile: 0.02 M Phosphate buffer (pH 3.0) (35:65) | UV | 225 | Oral suspension | africaresearchconnects.com |
C18-Pentafluorophenyl | Water and Acetonitrile (gradient) | DAD | Not specified | Drinking and river water | mdpi.com |
Waters acquity BEH C18 | Phosphate buffer (pH 6.8): Methanol:Acetonitrile (75:25) (gradient) | PDA | 225 | Bulk form and formulation | nih.govoup.com |
Apollo C18 | 0.01 M KH2PO4 – methanol (45:55) | DAD | 225 | Capsules (simultaneous with Amoxicillin) | nih.gov |
RP-8 | Not specified | Not specified | Not specified | Serum and urine | nih.gov |
Mass Spectrometry (MS) and Tandem Mass Spectrometry (LC-MS/MS) for Detection and Characterization
Liquid Chromatography coupled with Mass Spectrometry (LC-MS) and Tandem Mass Spectrometry (LC-MS/MS) are powerful techniques that provide superior sensitivity and selectivity for the analysis of this compound, especially in complex biological matrices. mdpi.comnih.govmdpi.com These methods are considered the gold standard for routine analysis in such matrices due to their ability to provide structural information for definitive identification. mdpi.comresearchgate.net
LC-MS/MS methods have been developed for the quantification of this compound in various samples, including human plasma, microdialysis samples, and milk. nih.govmdpi.com For example, a validated LC-MS/MS assay was developed for determining fluthis compound and this compound in microdialysis samples, demonstrating high sensitivity with a low limit of quantification. nih.gov Another study utilized LC-MS/MS to detect this compound residues in raw milk, highlighting its capability to identify compounds at very low concentrations. mdpi.com Turbulent flow liquid chromatography coupled to high-resolution mass spectrometry has also been used for the determination of this compound and its active metabolites in plasma and cerebrospinal fluid (CSF). nih.gov
Particle beam liquid chromatography-mass spectrometry with negative ion chemical ionization has been used for the confirmation of this compound residues in bovine muscle. researchgate.net This method achieved the specificity required for regulatory confirmation by monitoring five fragment ions for the compound. researchgate.net
Gas Chromatography (GC) Applications
Gas Chromatography (GC) is generally less suitable for the direct analysis of intact this compound due to the drug's low volatility and thermal instability. scirp.org However, with appropriate derivatization to create more volatile and thermally stable compounds, GC can be applied. While direct applications for this compound quantification are not widespread, GC is a powerful tool in pharmaceutical analysis for applications such as residual solvent analysis and the determination of certain impurities. scirp.org Some analytical standard providers indicate that this compound is suitable for GC, likely after derivatization. sigmaaldrich.com The combination of GC with mass spectrometry (GC-MS) is extensively used in metabolomics studies, which could have applications in understanding the metabolic fate of this compound. scirp.org
Advanced Sample Preparation Techniques for this compound Analysis in Complex Matrices
Effective sample preparation is a critical step to remove interfering substances and concentrate the analyte, especially when analyzing this compound in complex matrices like biological fluids, food, and environmental samples. tandfonline.commdpi.comresearchgate.net
Molecularly Imprinted Polymers (MIPs) for Selective Extraction
Molecularly Imprinted Polymers (MIPs) are highly selective synthetic materials designed to bind a specific target molecule. mdpi.comnih.gov They are created by polymerizing functional monomers and cross-linkers in the presence of a template molecule (in this case, this compound or a structural analog). mdpi.comnih.gov After polymerization, the template is removed, leaving behind specific recognition sites.
MIPs have been successfully used as selective sorbents in solid-phase extraction (MISPE) for the quantitative extraction of this compound from water and milk samples. mdpi.comnih.govnih.gov One study described the synthesis of a this compound-imprinted polymer using methacrylic acid as the functional monomer and ethylene glycol dimethacrylate as the cross-linker. mdpi.com This MIP exhibited high adsorption capacity and selectivity for this compound, enabling its determination in drinking and river water with high recovery rates. mdpi.comnih.gov Another study developed class-selective MIPs for the analysis of beta-lactamase-resistant penicillins, including this compound, in milk samples, demonstrating the utility of this technique for related compounds. nih.gov
Interactive Table: Molecularly Imprinted Polymer Synthesis for this compound Extraction
Component | Function | Example Material | Reference |
Template | Creates specific binding sites | This compound, 2-Biphenylylpenicillin | mdpi.comnih.gov |
Functional Monomer | Interacts with the template | Methacrylic acid (MAA), N-(2-aminoethyl)methacrylamide | mdpi.comnih.govresearchgate.net |
Cross-linker | Forms the polymer matrix | Ethyleneglycoldimethacrylate (EGDMA), Trimethylolpropane trimethacrylate | mdpi.comnih.govresearchgate.net |
Initiator | Starts the polymerization process | AIBN (2,2'-Azobis(2-methylpropionitrile)) | mdpi.comresearchgate.net |
Porogen | Solvent that creates pores in the polymer | Acetonitrile, Toluene | mdpi.comresearchgate.net |
Liquid-Liquid Extraction Methodologies
Liquid-Liquid Extraction (LLE) is a conventional and widely used sample preparation technique based on the partitioning of a solute between two immiscible liquid phases. researchgate.netjssuni.edu.in It is often employed for the extraction of this compound from various matrices. jssuni.edu.inmdpi.com
Simple LLE involves using an organic solvent, such as acetonitrile, to extract this compound from an aqueous sample. jssuni.edu.inmdpi.com For instance, a rapid LLE method using acetonitrile was developed for the isolation of six β-lactam antibiotic residues, including this compound, from bovine milk. mdpi.com In some cases, LLE is followed by a clean-up step like solid-phase extraction (SPE) to achieve better recovery and remove interferences, especially in complex food matrices like milk. jssuni.edu.in The choice of extraction solvent and the pH of the aqueous phase are critical parameters that are optimized to maximize the extraction efficiency. jssuni.edu.in
Impurity Profiling and Degradation Product Characterization
Impurity profiling is a comprehensive process that involves the detection, identification, and quantification of impurities in a drug substance. rroij.com For this compound, this process is crucial due to its propensity to form degradation and polymerized impurities that can impact its quality and potentially lead to adverse effects. nih.gov
Recent studies have utilized advanced analytical techniques to identify and characterize impurities in this compound. A study employing reversed-phase high-performance liquid chromatography (RP-HPLC) coupled with ion trap/time-of-flight mass spectrometry (MS) successfully elucidated the structures of 10 previously unknown impurities in this compound. nih.gov Among these, three were identified as polymerized impurities. nih.gov
Commonly identified degradation products of penicillins like this compound include penicilloic acids, which result from the hydrolysis of the β-lactam ring. Specifically for this compound, key impurities include:
This compound Penicilloic Acid (Impurity A): Formed through the hydrolysis of the β-lactam ring, which renders the molecule pharmacologically inactive.
3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic Acid (Impurity D): This impurity arises from the cleavage of the amide bond connecting the side chain to the β-lactam core.
This compound Penicillamide (Impurity E): A degradation product resulting from the breakdown of the thiazolidine ring.
The presence of polymerized impurities is a significant concern for penicillins, including this compound, as they have been associated with allergic reactions. nih.govresearchgate.net Techniques like high-performance size exclusion chromatography (HPSEC) and two-dimensional liquid chromatography (2D-LC) have been employed to separate and characterize these high-molecular-weight impurities. researchgate.netmdpi.com
Identified this compound Impurities
Impurity Name | Formation Pathway |
---|---|
This compound Penicilloic Acid (Impurity A) | Hydrolysis of the β-lactam ring |
3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic Acid (Impurity D) | Cleavage of the amide bond |
This compound Penicillamide (Impurity E) | Degradation of the thiazolidine ring |
Polymerized Impurities | Polymerization reactions nih.govresearchgate.net |
The formation of impurities in this compound primarily occurs through hydrolysis and polymerization reactions. nih.gov
Hydrolysis: The β-lactam ring, a core structural feature of penicillins, is susceptible to hydrolysis, leading to the formation of the corresponding penicilloic acid. This reaction is a major degradation pathway for this compound, resulting in the inactive this compound Penicilloic Acid. The hydrolysis of the amide linkage is another degradation route, yielding the side-chain derivative, 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxylic acid.
Polymerization: this compound can undergo polymerization, especially under conditions of high humidity and temperature. nih.govresearchgate.net These reactions can lead to the formation of dimers and higher-order polymers. nih.govresearchgate.net The mechanisms of polymerization are complex and can involve the opening of the β-lactam ring and subsequent reactions between this compound molecules. The presence of these polymerized impurities is a critical quality attribute to monitor due to their potential to trigger allergic responses. nih.govresearchgate.netmdpi.com
The structural elucidation of this compound impurities relies heavily on a combination of spectroscopic techniques. rroij.comijpacr.com
Nuclear Magnetic Resonance (NMR) Spectroscopy: Both ¹H and ¹³C NMR are powerful tools for determining the precise molecular structure of isolated impurities. researchgate.net Two-dimensional NMR techniques can provide further detailed information about the connectivity of atoms within the molecule.
Fourier-Transform Infrared (FT-IR) Spectroscopy: FT-IR spectroscopy is instrumental in identifying the functional groups present in the impurity molecules. ijpacr.comresearchgate.net The presence or absence of characteristic absorption bands, such as the β-lactam carbonyl stretch, can confirm degradation pathways like hydrolysis. researchgate.net
Mass Spectrometry (MS): Often coupled with liquid chromatography (LC-MS), mass spectrometry provides crucial information about the molecular weight of the impurities. nih.govnih.gov High-resolution mass spectrometry (HRMS) can help determine the elemental composition, further aiding in structure elucidation. nih.gov
These spectroscopic methods, often used in conjunction, provide the necessary data to definitively identify and characterize the structure of unknown impurities. rroij.comnih.gov
Elucidation of Impurity Formation Mechanisms (e.g., Hydrolysis, Polymerization)
Stability Studies and Degradation Kinetics in Controlled Environments
Stability studies are essential to understand how the quality of this compound varies with time under the influence of environmental factors such as temperature, humidity, and pH. mdpi.com These studies are crucial for determining appropriate storage conditions and shelf-life.
The degradation kinetics of this compound have been investigated under various conditions. In aqueous solutions, the degradation of penicillins like amoxicillin has been shown to follow pseudo-first-order kinetics. nih.gov The degradation rate is significantly influenced by pH, with both specific-acid and specific-base catalysis observed. nih.gov
A study on the degradation kinetics of this compound sodium revealed that the degradation process is dependent on the solvent system. researchgate.net In methanol, the degradation followed zero-order kinetics, while the addition of butyl acetate shifted the kinetics to first-order and accelerated the degradation. researchgate.net The pH of the system also played a critical role in the degradation rate. researchgate.net The apparent activation energy for the degradation of this compound in an aqueous solution was determined to be 80.34 ± 5.88 kJ mol⁻¹. researchgate.net
Forced degradation studies, where the drug substance is exposed to stress conditions such as acid, base, oxidation, heat, and light, are performed to identify potential degradation products and establish the degradation pathways. mdpi.comneliti.com For instance, a study on amoxicillin and this compound in a combined dosage form utilized RP-HPLC to assess their stability under various stress conditions, demonstrating the method's specificity for the drugs in the presence of their degradation products. neliti.com
The stability of this compound formulations can also be influenced by excipients. In a study on fluthis compound, a closely related isoxazolyl penicillin, it was found that the choice and amount of excipient significantly impacted the stability of the drug in a high-humidity environment. innovareacademics.in
Kinetic Parameters of this compound Degradation
Condition | Kinetic Order | Key Findings | Reference |
---|---|---|---|
In Methanol | Zero-order | - | researchgate.net |
In Methanol/Butyl Acetate | First-order | Butyl acetate accelerates degradation. | researchgate.net |
In Aqueous Solution | Pseudo-first-order | pH-dependent degradation rate. Apparent activation energy of 80.34 ± 5.88 kJ mol⁻¹. | researchgate.netnih.gov |
Future Research Directions and Translational Perspectives Academic Focus
Exploration of Novel Therapeutic Strategies to Counter Antimicrobial Resistance
Antimicrobial resistance (AMR) is a significant global health threat, driven by various bacterial mechanisms including enzymatic degradation (e.g., beta-lactamases), modifications to drug targets (such as PBPs), altered cell membrane permeability, and the overexpression of efflux pumps mims.commims.comoup.commims.comnih.gov. While cloxacillin is effective against beta-lactamase-producing Staphylococcus species, it is generally not effective against methicillin-resistant Staphylococcus aureus (MRSA), which remains a major clinical challenge wikipedia.orgwikipedia.orgflybase.orgwikidata.org.
Future research directions aim to circumvent these resistance mechanisms by exploring novel therapeutic strategies. This includes the investigation of compounds that can potentiate this compound's activity against resistant strains. For instance, studies have shown that certain dihydropyridine derivatives can enhance the antibacterial effect of this compound against this compound-resistant MRSA strains. One such compound, 6g, demonstrated a 329% potentiation of this compound's activity against MRSA1 at a concentration of 1000 µ g/disc flybase.orgontosight.ai. This suggests a promising avenue for developing adjunctive therapies that restore or augment this compound's effectiveness. Other emerging approaches to combat AMR include the development of biofilm-disrupting agents, quorum-sensing inhibitors, and advanced nanoparticle-based drug delivery systems, all of which could potentially be combined with or enhance the action of this compound mims.com.
Application of Advanced Computational and Bioinformatic Tools in this compound Research
Advanced computational and bioinformatic tools are increasingly indispensable in modern drug discovery and antimicrobial resistance research, offering efficient ways to understand drug mechanisms, predict interactions, and design new compounds. In this compound research, molecular docking studies have been extensively utilized to analyze its binding characteristics with bacterial proteins. These studies have investigated this compound's interaction with targets such as the AmpC beta-lactamase receptor (1FCM) and various penicillin-binding proteins (PBPs) fishersci.fimims.comwikipedia.orgfishersci.ca.
Computational methods can predict the binding affinities of this compound and its derivatives, as well as identify key amino acid residues involved in these interactions. For example, in silico studies have revealed that this compound exhibits strong binding affinities for the PBPs of Neisseria sicca and Escherichia coli mims.com. Tools like AutoDock Vina facilitate these docking simulations, allowing researchers to explore numerous structural modifications to this compound and predict their potential impact on binding affinity and efficacy fishersci.fi.
Beyond molecular docking, broader bioinformatics approaches are applied for the in silico detection and characterization of antimicrobial resistance phenotypes and genes. These tools process high-throughput sequencing data from clinical and environmental samples, employing methods such as alignment-based analysis, k-mer based genomic signatures, and machine learning algorithms nih.govnih.govnih.gov. The integration of structural biology databases (e.g., Protein Data Bank (PDB), Structural Classification of Proteins (SCOP), InterPro, AlphaFold DB) with computational modeling techniques enables a deeper understanding of protein structures and their interactions with this compound, aiding in the rational design of new antibacterial agents nih.gov.
Development of this compound-Based Combination Therapies for Enhanced Efficacy
Studies have demonstrated that combining this compound with daptomycin can lead to enhanced efficacy against MRSA bacteremia and foreign-body infections. This combination has been shown to improve the bactericidal activity of daptomycin, especially against bacteria in the log phase of growth wikipedia.orgwikipedia.orgfishersci.cafishersci.ca. While the exact mechanism is not fully elucidated, it is hypothesized that daptomycin's action on the Gram-positive cell membrane may improve the activity of beta-lactams like this compound against MRSA wikipedia.org.
In another experimental model of Staphylococcus aureus endocarditis, the addition of fosfomycin or this compound to daptomycin significantly improved the efficacy of daptomycin in sterilizing vegetations, outperforming this compound monotherapy or this compound combined with gentamicin rcsb.org. Furthermore, this compound has been shown to reduce the minimum inhibitory concentrations (MICs) of carbapenems (like imipenem and meropenem) and cephalosporins (like ceftazidime and cefepime) in carbapenem-resistant Pseudomonas aeruginosa isolates, particularly when AmpC beta-lactamase overexpression is a contributing resistance mechanism fishersci.ca.
Beyond traditional antibiotics, multi-drug combinations involving this compound are being investigated. For example, a three-drug combination of this compound, thioridazine, and tetracycline demonstrated synergistic anti-Staphylococcal activity in vitro by inhibiting bacterial efflux pumps and autolysins rcsb.org. The strategic use of beta-lactamase inhibitors, such as clavulanic acid and avibactam, in combination with beta-lactam antibiotics is a well-established approach to restore antibiotic efficacy by neutralizing the enzymes that degrade them mims.commims.comsynhet.com. While this compound itself is beta-lactamase resistant, its inclusion in broader combination regimens can contribute to a more robust and effective therapeutic approach against complex resistant infections.
Innovations in this compound Synthesis and Formulation Technologies
Innovations in synthesis and formulation technologies are critical for improving the therapeutic profile of this compound, addressing challenges such as bioavailability, stability, and targeted delivery.
Research has focused on developing novel drug delivery systems for this compound. For instance, this compound-loaded Poly(D,L-Lactide-Co-Glycolide) Acid (PLGA) nanoparticles have been synthesized using methods like single emulsion solvent evaporation wikidata.org. These nanoparticles aim to enhance the antimicrobial efficiency of this compound, particularly against intracellular bacteria and under acidic pH conditions, by potentially co-localizing the drug with the bacteria within intracellular compartments wikidata.org.
In the realm of oral formulations, efforts have been made to develop tasteless dispersible tablets containing this compound, often in combination with other antibiotics like ampicillin. Techniques such as incorporating microspheres for taste masking and utilizing wet granulation methods are employed to achieve patient acceptability and rapid disintegration researchgate.netuni.lu.
To address issues of low bioavailability and short plasma half-life, the development of gastroretentive microspheres of this compound has been explored. Polymers like Eudragit RS 100 and Kollicoat MAE 100P are used to create these microspheres, aiming for a controlled release of the drug over an extended period, thereby improving its pharmacokinetic profile dsmz.de.
Furthermore, novel synthetic approaches are being investigated to produce this compound sodium with higher purity, reduced impurity content, enhanced stability, and shorter production times mims.com. In addition to traditional synthesis, polymerizable cholinium-based antibiotics have been designed to act as polymer carriers for this compound, leading to the creation of single and dual-drug delivery systems that can ionically bond the drug anion to the polymer matrix wikipedia.org. The synthesis of molecularly imprinted polymers (MIPs) for the selective solid-phase extraction of this compound also highlights advancements in purification and analytical technologies relevant to its production and quality control nih.gov.
Q & A
Basic Research Questions
Q. What analytical methods are validated for trace-level detection of cloxacillin in biological matrices, and how are their sensitivity and reproducibility ensured?
- Methodology : Magnetic molecularly imprinted polymer (MMIP)-based extraction combined with surface-enhanced Raman spectroscopy (SERS) enables quantitative detection of this compound in pig serum. The MMIP microspheres use a core-shell structure with superparamagnetic iron oxide cores and silicon nanopillars for selective binding. Validation includes recovery tests (85–126%) and achieving a limit of detection (LOD) of 7.8 pmol. Cross-laboratory reproducibility requires standardized protocols for MMIP synthesis and SERS substrate preparation .
Q. How is this compound’s coordination chemistry characterized in metal complexes, and what insights does this provide into its antimicrobial activity?
- Methodology : Infrared (IR) spectroscopy and elemental analysis are used to determine the binding modes of this compound in metal(II) complexes (e.g., Fe, Cu). This compound typically acts as a bidentate ligand, coordinating via the β-lactam carbonyl oxygen and the carboxylate group. Magnetic moment measurements and conductivity data reveal octahedral geometries (e.g., [Fe(clox)₂Cl₂]), which influence solubility and bioavailability. These structural insights guide hypotheses about enhanced antimicrobial efficacy through metal synergism .
Q. What experimental models are suitable for evaluating this compound’s efficacy against methicillin-resistant Staphylococcus aureus (MRSA)?
- Methodology : Rabbit models of experimental endocarditis are employed to simulate MRSA infections. Inoculation with MRSA strains followed by this compound monotherapy or combination therapy (e.g., vancomycin + this compound) allows comparative analysis of bacterial load reduction, valve vegetation weight, and histopathology. Synergy is assessed via fractional inhibitory concentration (FIC) indices and time-kill assays .
Advanced Research Questions
Q. How can spectroscopic techniques (e.g., IR, magnetic susceptibility) resolve contradictions in proposed structures of this compound-metal complexes?
- Methodology : Discrepancies in coordination geometry (e.g., tetrahedral vs. octahedral) are addressed through complementary techniques:
- IR spectroscopy : Identifies shifts in υ(C=O) and υ(COO⁻) bands to confirm binding sites.
- Magnetic susceptibility : Distinguishes high-spin (octahedral) vs. low-spin (square planar) complexes.
- Elemental analysis : Validates stoichiometry (e.g., C, H, N, and metal content). Divergent results necessitate recalibration of synthesis conditions (e.g., solvent, pH) .
Q. What statistical approaches optimize this compound adsorption in environmental remediation studies, and how are confounding variables controlled?
- Methodology : Response surface methodology (RSM) with Box-Behnken design (BBD) is used to model interactions between variables (pH, contact time, adsorbent dose, initial concentration). For Fe-CCS-g-β-CD adsorbents, ANOVA identifies pH (6.5) and contact time (40 min) as critical factors for 99.93% removal efficiency. Confounding variables (e.g., temperature, ionic strength) are minimized via controlled batch experiments .
Q. How does metabolomic profiling differentiate this compound’s effective vs. ineffective treatments in vivo?
- Methodology : Serum metabolomics using LC-MS or GC-MS identifies biomarkers (e.g., amino acids, lipids) altered by this compound treatment. In murine models, ineffective MRSA treatment shows metabolite profiles resembling untreated controls, while effective MSSA treatment aligns with uninfected mice. Multivariate analysis (PCA, OPLS-DA) highlights pathways like TCA cycle disruption and oxidative stress, correlating with bacterial clearance .
Q. What experimental designs validate this compound’s synergy with β-lactamase inhibitors in overcoming resistance?
- Methodology : Checkerboard assays and time-kill curves quantify synergy between this compound and inhibitors (e.g., clavulanic acid). FIC indices <0.5 indicate synergy. Genotypic analysis (PCR for blaZ genes) and phenotypic assays (Nitrocefin hydrolysis) confirm β-lactamase inhibition. Contradictory results (e.g., indifference in certain strains) require reevaluation of inhibitor concentration or resistance mechanisms (e.g., altered penicillin-binding proteins) .
Methodological Guidelines
- Data Presentation : Tables/figures must include error margins (e.g., ±SD) and statistical significance (p <0.05). For adsorption studies, report R² values for RSM models .
- Reproducibility : Detailed synthesis protocols (e.g., MMIP core-shell fabrication) and instrument parameters (e.g., SERS laser wavelength) are critical .
- Ethical Compliance : In vivo studies require institutional approval (e.g., IACUC) and adherence to ARRIVE guidelines for animal research .
Retrosynthesis Analysis
AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.
One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.
Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.
Strategy Settings
Precursor scoring | Relevance Heuristic |
---|---|
Min. plausibility | 0.01 |
Model | Template_relevance |
Template Set | Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis |
Top-N result to add to graph | 6 |
Feasible Synthetic Routes
Featured Recommendations
Most viewed | ||
---|---|---|
Most popular with customers |
Disclaimer and Information on In-Vitro Research Products
Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.